Knowledge of human papillomavirus infection and its prevention among adolescents and parents in the greater Milan area, Northern Italy

Pelucchi, Claudio; Esposito, Susanna; Galeone, Carlotta; Semino, Margherita; Sabatini, Caterina; Picciolli, Irene; Consolo, Silvia; Milani, Gregorio; Principi, Nicola
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p378
Academic Journal
Background: In order to be widely accepted by users, the implementation of a new health intervention requires them to be adequately informed about its clinical importance, benefits and risks. The aim of this study was to provide data on the knowledge of Italian adolescents and parents concerning human papillomavirus (HPV) infection and its prevention in order to allow the development of adequate training programmes. Methods: Between 2 May and 15 June 2008, we made a cross-sectional survey of 863 high school students and 2,331 parents of middle and high school students using two anonymously completed questionnaires covering the knowledge of HPV infection and related diseases, and attitudes to vaccinations. The approached schools were a convenience sample of the schools of the greater Milan area, Northern Italy. Results: More mothers than fathers were aware that HPV infection could concern their children (58% vs 53%; p = 0.004) and were favourable towards vaccinating their children against HPV (68% vs 65%; p = 0.03); among the students, more females than males were aware that HPV infection could concern themselves (45% vs 26%; p < 0.001) and would undergo vaccination against HPV (68% vs 40%; p < 0.001). The parents' propensity to vaccinate their children against HPV was significantly associated with professing the Catholic religion (odds ratio - OR = 0.61, 95% confidence interval - CI 0.46-0.82, being atheist), the gender of the offspring (OR = 1.88, 95% CI 1.53-2.30, having at least one daughter), a propensity to vaccinations in general (OR = 23.1, 95% CI 13.7-38.8), a knowledge that HPV vaccine is aimed at preventing cervical cancer (OR = 2.31, 95% CI 1.69-3.16), and an awareness that HPV could affect their own children (OR = 3.52, 95% CI 2.89-4.29). The students who were aware that HPV infection could affect themselves were more in favour of to HPV vaccination, regardless of whether they were male (OR = 5.73, 95% CI 2.85-11.5) or female (OR = 2.39, 95% CI 1.66-3.46). Conclusions: Both students and parents seem to underestimate the likelihood of HPV infection, and this is associated with a lower propensity for vaccination. This is an important indication for future training programmes concerning HPV prevention designed to increase the acceptance of HPV vaccine in families.


Related Articles

  • HPV and Cervical Cancer. Leaver, Dennis; Labonte, Geri // Radiation Therapist;Spring2010, Vol. 19 Issue 1, p27 

    Human papillomaviruses (HPVs) are estimated to cause a half million cases of cervical cancer worldwide each year. This article reviews the connection between HPVs and cervical cancer, discusses the HPV vaccine and provides an overview of cervical cancer symptoms, staging and treatment. Case...

  • The HPV vaccine: An analysis of the FUTURE II study. Howard, Michelle; Lytwyn, Alice // Canadian Family Physician;Dec2007, Vol. 53 Issue 12, p2157 

    The article analyzes the efficacy of Gardasil, a vaccine, in treating human papillomavirus (HPV) diseases. It is a randomized double-blind placebo-controlled trial which evaluate the effectiveness of the vaccine for HPV types 6, 11, 16, and 18. The research cites that Gardasil vaccine is...

  • What If Preventing Cancer Is as Easy as Being Vaccinated? Biedrzycki, Barbara A. // ONS News;Aug2006, Vol. 21 Issue 8, p9 

    The article reports on the development of a human papillomavirus (HPV) vaccine intended for the prevention of cervical cancer among men and women worldwide. HPV has been sought to be the most common sexually transmitted disease with 20 million men and women have been infected. With the approval...

  • Selecting a Mix of Prevention Strategies against Cervical Cancer for Maximum Efficiency with an Optimization Program. Demarteau, Nadia; Breuer, Thomas; Standaert, Baudouin // PharmacoEconomics;2012, Vol. 30 Issue 4, p337 

    Background: Screening and vaccination against human papillomavirus (HPV) can protect against cervical cancer. Neither alone can provide 100% protection. Consequently it raises the important question about the most efficient combination of screening at specified time intervals and vaccination to...

  • Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception? Licht, Andrea S.; Murphy, Jill M.; Hyland, Andrew J.; Fix, Brian V.; Hawk, Larry W.; Mahoney, Martin C. // Sexually Transmitted Infections;Feb2010, Vol. 86 Issue 1, p19 

    Background Few studies have examined factors associated with the actual use of the human papillomavirus (HPV) vaccine since licensure in 2006. The aims of this study were to assess HPV vaccination rates and to examine whether knowledge and risk perceptions regarding HPV were associated with the...

  • Ethical considerations of universal vaccination against human papilloma virus. Navarro-Illana, Pedro; Aznar, Justo; Díez-Domingo, Javier // BMC Medical Ethics;2014, Vol. 15 Issue 1, p1 

    Background From an epidemiological perspective, the practice of universal vaccination of girls and young women in order to prevent human papilloma virus (HPV) infection and potential development of cervical cancer is widely accepted even though it may lead to the neglect of other preventive...

  • News.  // MLO: Medical Laboratory Observer;Dec2004, Vol. 36 Issue 12, p6 

    This article presents news related to medical care. As of Jan 1, 2005, the National Committee for Clinical Laboratory Standards will be known as the Clinical and Laboratory Standards Institute. An experimental human papilloma virus (HPV) vaccine developed by Merck & Co. has been effective in...

  • Viral vaccines forge ahead. Jesitus, John // Dermatology Times;Jan2008, Vol. 29 Issue 1, p40 

    The article reports on the views of Stephen K. Tyring, professor of dermatology at the University of Texas Health Science Center in Houston, regarding the efficacy of viral vaccines such as the human papilloma virus (HPV) vaccine Gardasil. According to Tyring, the HPV vaccine continues to be...

  • Protecting the Next Generation: What Is the Role of the Duration of Human Papillomavirus Vaccine-Related Immunity? Günther, Oliver P.; Ogilvie, Gina; Naus, Monika; Young, Eric; Patrick, David M.; Dobson, Simon; Duval, Bernard; Noël, Pierre-André; Marra, Fawziah; Miller, Dianne; Brunham, Robert C.; Pourbohloul, Babak // Journal of Infectious Diseases;6/15/2008, Vol. 197 Issue 12, p1653 

    Background. There is strong evidence that human papillomavirus (HPV) is necessary for the development of cervical cancer. A prophylactic HPV vaccine with high reported efficacy was approved in North America in 2006. Methods. A mathematical model of HPV transmission dynamics was used to simulate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics